Francis Crick scientists reveal how cells ‘raise the alarm’ when damaged or infected
The V-ATPase protein, V1H, was found to be involved in the process of raising the alarm
Read More
Tag: Francis Crick Institute
MRC grants researcher £1.2m to further understand complex secretory processes
The research will help to better understand how this pathway is coordinated in the cell
Read More
Cystic fibrosis drug improves outcomes in severe COVID-19 pneumonia
Genentech’s Pulmozyme could also treat other respiratory infections and conditions
Read More
Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments
Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer
Read More
Researchers design genetic mole reversal therapy for rare skin condition
Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children
Read More
Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients
Read More
New study reveals how brain cell communication is linked to Alzheimer’s disease
Two support cells, microglia and astrocytes, were found to communicate with each other
Read More
The Crick announces new partnerships with SMEs and MRC for research
The projects will focus on a range of research areas, including Down’s syndrome and ALS
Read More
Francis Crick Institute and Broken String Biosciences partner for ALS research
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
Read More
Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
Bacteroides fragilis in the gut improves immunity and immunotherapy treatment responses
Read More
Francis Crick researchers reveal pathways linking intestinal inflammation and colitis
Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis
Read More
Study suggests tumour microenvironments could predict cancer progression
NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
